American Oncology Network Statistics
Share Statistics
American Oncology Network has 27.10M shares outstanding. The number of shares has increased by -60.92% in one year.
| Shares Outstanding | 27.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 27.68% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.56M |
| Failed to Deliver (FTD) Shares | 310 |
| FTD / Avg. Volume | 7.94% |
Short Selling Information
The latest short interest is 10.81K, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 10.81K |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.63 |
Valuation Ratios
The PE ratio is -7.12 and the forward PE ratio is null.
| PE Ratio | -7.12 |
| Forward PE | null |
| PS Ratio | 0.03 |
| Forward PS | null |
| PB Ratio | -0.24 |
| P/FCF Ratio | -1.3 |
| PEG Ratio | n/a |
Enterprise Valuation
American Oncology Network Inc. has an Enterprise Value (EV) of 138.81M.
| EV / Earnings | -25.05 |
| EV / Sales | 0.11 |
| EV / EBITDA | -3.53 |
| EV / EBIT | -2.82 |
| EV / FCF | -4.57 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of -0.5.
| Current Ratio | 1.64 |
| Quick Ratio | 1.38 |
| Debt / Equity | -0.5 |
| Total Debt / Capitalization | -99.45 |
| Cash Flow / Debt | -0.22 |
| Interest Coverage | -7.66 |
Financial Efficiency
Return on equity (ROE) is 0.03% and return on capital (ROIC) is -36.89%.
| Return on Equity (ROE) | 0.03% |
| Return on Assets (ROA) | -0.01% |
| Return on Capital (ROIC) | -36.89% |
| Revenue Per Employee | 838.81K |
| Profits Per Employee | -3.63K |
| Employee Count | 1.52K |
| Asset Turnover | 3.42 |
| Inventory Turnover | 26.84 |
Taxes
| Income Tax | 384.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -23.4% in the last 52 weeks. The beta is 0.38, so American Oncology Network 's price volatility has been higher than the market average.
| Beta | 0.38 |
| 52-Week Price Change | -23.4% |
| 50-Day Moving Average | 3.68 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 58.65 |
| Average Volume (20 Days) | 3.91K |
Income Statement
In the last 12 months, American Oncology Network had revenue of $1.28B and earned -$5.54M in profits. Earnings per share was $-1.36.
| Revenue | 1.28B |
| Gross Profit | 82.80M |
| Operating Income | -49.15M |
| Net Income | -5.54M |
| EBITDA | -39.35M |
| EBIT | -49.15M |
| Earnings Per Share (EPS) | -1.36 |
Balance Sheet
The company has $28.54M in cash and $128.32M in debt, giving a net cash position of -$99.79M.
| Cash & Cash Equivalents | 28.54M |
| Total Debt | 128.32M |
| Net Cash | -99.79M |
| Retained Earnings | -161.81M |
| Total Assets | 394.81M |
| Working Capital | 71.37M |
Cash Flow
In the last 12 months, operating cash flow was -$18.12M and capital expenditures -$12.28M, giving a free cash flow of -$30.40M.
| Operating Cash Flow | -18.12M |
| Capital Expenditures | -12.28M |
| Free Cash Flow | -30.40M |
| FCF Per Share | -4.55 |
Margins
Gross margin is 6.47%, with operating and profit margins of -3.84% and -0.43%.
| Gross Margin | 6.47% |
| Operating Margin | -3.84% |
| Pretax Margin | -4.89% |
| Profit Margin | -0.43% |
| EBITDA Margin | -3.08% |
| EBIT Margin | -3.84% |
| FCF Margin | -2.38% |
Dividends & Yields
AONC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -29.89% |
| FCF Yield | -24.63% |
Analyst Forecast
Currently there are no analyst rating for AONC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 3.75 |
| Piotroski F-Score | 3 |